한국어
English
日本語
中文(简体)
Sibinko Tablet 50 mg (Abrocitinib)
50mg
Tablet · Prescription medication
Pfizer Korea Co., Ltd.
Abrocitinib is an immunosuppressive ingredient used in the treatment of atopic dermatitis.
MFDS ingredient code M281729
Abrocitinib is a drug that belongs to the Janus kinase (JAK) inhibitor class, primarily used for the treatment of atopic dermatitis. This ingredient plays a role in modulating the immune response to reduce skin inflammation and itching.
Abrocitinib reduces the production of inflammatory substances by blocking the JAK enzymes, which are signaling pathways within immune cells. As a result, skin inflammation and itching are alleviated, improving symptoms.
Approved uses differ by product. Check each product's information for its actual use.
Abrocitinib is characterized by its selective action compared to other JAK inhibitors, which reduces the risk of side effects. It is also taken orally, differentiating it from topical medications applied directly to the skin.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
3 total
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
